Turning Point Brands Inc is a tobacco business based in the US. Turning Point Brands shares (TPB) are listed on the NYSE and all prices are listed in US Dollars. Turning Point Brands employs 408 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $34.50 |
|---|---|
| 52-week range | $35.06 - $60.78 |
| 50-day moving average | $37.66 |
| 200-day moving average | $44.48 |
| Wall St. target price | $57.75 |
| PE ratio | 15.4521 |
| Dividend yield | $0.215 (0.59%) |
| Earnings per share (TTM) | $2.60 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $34.5 from 2022-01-21
| 1 week (2022-01-14) | -6.17% |
|---|---|
| 1 month (2021-12-23) | -5.81% |
| 3 months (2021-10-22) | -27.37% |
| 6 months (2021-07-23) | -24.26% |
| 1 year (2021-01-22) | -23.74% |
|---|---|
| 2 years (2020-01-24) | 33.93% |
| 3 years (2019-01-24) | 6.91% |
| 5 years (2017-01-24) | 168.27% |
Valuing Turning Point Brands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Turning Point Brands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Turning Point Brands's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Turning Point Brands shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Turning Point Brands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $115.7 million.
The EBITDA is a measure of a Turning Point Brands's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $445.5 million |
|---|---|
| Operating margin TTM | 24.85% |
| Gross profit TTM | $189.6 million |
| Return on assets TTM | 12.55% |
| Return on equity TTM | 4183.3% |
| Profit margin | 11.19% |
| Book value | $7.30 |
| Market capitalisation | $694 million |
TTM: trailing 12 months
Dividend payout ratio: 8.46% of net profits
Recently Turning Point Brands has paid out, on average, around 8.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Turning Point Brands shareholders could enjoy a 0.59% return on their shares, in the form of dividend payments. In Turning Point Brands's case, that would currently equate to about $0.215 per share.
While Turning Point Brands's payout ratio might seem low, this can signify that Turning Point Brands is investing more in its future growth.
Turning Point Brands's most recent dividend payout was on 6 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 15 December 2021 (the "ex-dividend date").
Over the last 12 months, Turning Point Brands's shares have ranged in value from as little as $35.06 up to $60.7759. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Turning Point Brands's is 0.4019. This would suggest that Turning Point Brands's shares are less volatile than average (for this exchange).
Turning Point Brands, Inc. , together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker's Products, and NewGen Products. The Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products under the Zig-Zag brand. The Stoker's Products segment manufactures and markets moist snuff tobacco and loose-leaf chewing tobacco products under the Stoker's, Beech-Nut, and Trophy brands. The NewGen Products segment markets and distributes cannabidiol isolate, liquid vapor products, and other products without tobacco and/or nicotine to individual consumers through VaporFi B2C online platform, as well as non-traditional retail through VaporBeast. The company sells its products to wholesale distributors and retail merchants in the independent and chain convenience stores, tobacco outlets, food stores, mass merchandising, and drug stores.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.